Disease-modifying therapy in vasculitides /
| Other Authors: | , |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Boston :
Birkhauser Verlag,
Basel ; ©2001.
|
| Series: | PIR (Series)
|
| Subjects: |
Table of Contents:
- Systemic vasculitides, an introduction
- Standard therapeutic regimens for vasculitis
- Tumor necrosis factor (TNF) inhibition in the treatment of vasculitis
- Methotrexate as an alternative to classic immunosuppressive therapies
- Intravenous immunoglobulin as immuno-modifying treatment
- T-cell directed treatment: anti-thymocyte globulin
- New immunosuppressants: mycophenolate mofetil and 15-deoxyspergualin
- Interferon-α for the treatment of virus-related systemic vasculitides
- Autologous stem cell therapy for systemic vasculitis
- Prevention of relapsing disease in anti-neutrophil cytoplasmic antibody related necrotizing small-vessel vasculitis: the role for autoantibody guided and anti-bacterial treatment.